TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
UroMedical Väst AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
68,403
|
62,783
|
60,331 |
Financial expenses |
417
|
5,282
|
1,533 |
Earnings before taxes |
10,970
|
-443
|
4,615 |
EBITDA |
11,928
|
5,991
|
7,111 |
Total assets |
21,893
|
30,828
|
28,695 |
Current assets |
9,447
|
18,392
|
14,394 |
Current liabilities |
7,214
|
16,148
|
12,894 |
Equity capital |
13,844
|
13,845
|
15,199 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
22
![]() |
22
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.2%
|
44.9%
|
53.0% |
Turnover per employee |
3,109
|
2,854
|
3,175 |
Profit as a percentage of turnover |
16.0%
|
-0.7%
|
7.6% |
Return on assets (ROA) |
52.0%
|
15.7%
|
21.4% |
Current ratio |
131.0%
|
113.9%
|
111.6% |
Return on equity (ROE) |
79.2%
|
-3.2%
|
30.4% |
Change turnover |
5,620
|
2,452
|
5,122 |
Change turnover % |
9%
|
4%
|
9% |
Chg. No. of employees |
0
|
3
|
4 |
Chg. No. of employees % |
0%
|
16%
|
27% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.